Curcumin and liver disease
- 10 January 2013
- journal article
- review article
- Published by Wiley in BioFactors
- Vol. 39 (1), 88-100
- https://doi.org/10.1002/biof.1057
Abstract
Liver diseases pose a major medical problem worldwide and a wide variety of herbs have been studied for the management of liver-related diseases. In this respect, curcumin has long been used in traditional medicine, and in recent years it has been the object of increasing research interest. In combating liver diseases, it seems clear that curcumin exerts a hypolipidic effect, which prevents the fatty acid accumulation in the hepatocytes that may result from metabolic imbalances, and which may cause nonalcoholic steatohepatitis. Another crucial protective activity of curcumin, not only in the context of chronic liver diseases but also regarding carcinogenesis and other age-related processes, is its potent antioxidant activity, which affects multiple processes and signaling pathways. The effects of curcumin on NF-κβ are crucial to our understanding of the potent hepatoprotective role of this herb-derived micronutrient. Because curcumin is a micronutrient that is closely related to cellular redox balance, its properties and activity give rise to a series of molecular reactions that in every case and biological situation affect the mitochondria. © 2013 BioFactors, 39(1):88–100, 2013This publication has 133 references indexed in Scilit:
- A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activationLaboratory Investigation, 2011
- The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in miceJournal of Hepatology, 2011
- Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1Laboratory Investigation, 2009
- CCR2 promotes hepatic fibrosis in miceJournal of Hepatology, 2009
- Immune Interactions in Hepatic FibrosisClinics in Liver Disease, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cellsLaboratory Investigation, 2008
- Liver cirrhosisThe Lancet, 2008
- Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcuminBioorganic & Medicinal Chemistry Letters, 2008
- NOX in liver fibrosisArchives of Biochemistry and Biophysics, 2007